Recent Articles from GlobeNewswire

SMAR DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Smartsheet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SMAR
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
SLM DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages SLM Corporation a/k/a Sallie Mae Investors to Secure Counsel Before Important February 17 Deadline in Securities Class Action – SLM
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
ROSEN, A LEADING LAW FIRM, Encourages Smart Digital Group Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SDM
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
Namib Minerals Commences Dewatering at Redwing Mine in Support of Restart Project
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today provided an update on progress at its Redwing Mine in Zimbabwe, confirming that dewatering activities commenced on January 29, 2026, in line with the work plan outlined in the Company’s November 2025 business update. The dewatering phase will enable access to the mine for feasibility studies, including underground condition assessments and detailed engineering evaluations, which will inform the next stages of the restart project at Redwing.
By Namib Minerals · Via GlobeNewswire · February 12, 2026
IREN Added to MSCI USA Index
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced it will be added to the MSCI USA Index, effective after close of trading on February 27, 2026.
By IREN · Via GlobeNewswire · February 12, 2026
An Update on Ring Partnership: Flock Safety Refocuses on Local Communities and Innovation
Atlanta, GA, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flock Safety, the leading safety technology platform dedicated to creating thriving communities, today announced it is pausing further exploration of a potential partnership with Ring.
By Flock Safety · Via GlobeNewswire · February 12, 2026
21shares Announces Distributions on TSOL
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Solana ETF (TSOL) for staking rewards earned from its SOL holdings.
By 21Shares · Via GlobeNewswire · February 12, 2026
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN® Nasal Spray. This approval expands the NARCAN® Nasal Spray product suite to include 6-count and 24-count multipack options, specifically designed to meet the needs of partners distributing higher volumes of naloxone. These new formats offer enhanced flexibility with the same trusted product, benefiting community programs and organizations operating large-scale, multi-site, or high-volume distribution programs.
By Emergent BioSolutions · Via GlobeNewswire · February 12, 2026
PLUG SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Plug Power, Inc. Investors - Contact Kirby McInerney LLP by April 3, 2026
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Plug Power, Inc. (“Plug Power” or the “Company”) (NASDAQ:PLUG) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
By Kirby McInerney LLP · Via GlobeNewswire · February 12, 2026
Concentrix Prices $600 Million Senior Notes Offering
NEWARK, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Concentrix Corporation (the “Company”) (NASDAQ: CNXC), a global technology and services leader, today announced that it has priced a public offering of $600 million aggregate principal amount of 6.500% Senior Notes due 2029 (the “Offering”). The Company expects to use the net proceeds from the Offering, together with other available funds, as necessary, to redeem or otherwise repay at or prior to maturity all or a portion of its 6.650% Senior Notes due August 2, 2026 (the “2026 Notes”), of which $800 million aggregate principal amount is outstanding as of the date hereof, and pay related fees and expenses. The Offering is expected to close on February 24, 2026, subject to customary closing conditions.
By Concentrix Solutions Corporation · Via GlobeNewswire · February 12, 2026
Calian Reports on the Election of Directors Voting Results
OTTAWA, Ontario, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The following matter was voted upon at the Annual Meeting of Shareholders of Calian® Group Ltd. (TSX:CGY), held on February 12, 2026, in Ottawa, Ontario. This and other matters voted upon are described in greater detail in the Notice of Annual Meeting of Shareholders and Management Proxy Circular dated December 15, 2025. 
By Calian Group Ltd. · Via GlobeNewswire · February 12, 2026
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bath & Body Works and BellRing Brands and Encourages Investors to Contact the Firm
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bath & Body Works, Inc. (NYSE:BBWI) and BellRing Brands, Inc. (NYSE:BRBR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2026
Spartacus Acquisition Corp. II Announces Closing of $230,000,000 Initial Public Offering
Austin, TX, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Spartacus Acquisition Corp. II (the “Company”) announced today that it closed its initial public offering of 23,000,000 units, at $10.00 per unit, including 3,000,000 units pursuant to the full exercise of the overallotment option by the underwriters. The units began trading on the Nasdaq Capital Market (“Nasdaq”) on Wednesday, February 11, 2026 under the ticker symbol “TMTSU.” Each unit consists of one share of the Company’s Class A ordinary share and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, shares of the Class A ordinary share and warrants are expected to be listed on Nasdaq under the symbols “TMTS” and “TMTSW,” respectively.  
By Spartacus Acquisition Corp. II · Via GlobeNewswire · February 12, 2026
NCLA Asks D.C. Court to Stop CPSC from Making Baseless Claims on Weighted Sleep Sacks for Babies
Dreamland Baby Co. v. Consumer Product Safety Commission, et al.
By New Civil Liberties Alliance · Via GlobeNewswire · February 12, 2026
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the fourth quarter and full year of 2025 before the open of trading on Friday, February 27, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.
By Treace Medical Concepts, Inc. · Via GlobeNewswire · February 12, 2026
Bragar Eagel & Squire, P.C. Reminds Smart Digital Group Investors With Large Losses to Contact the Firm Regarding Their Rights Before March 16th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Smart Digital (SDM) To Contact Him Directly To Discuss Their Options.
By Bragar Eagel & Squire · Via GlobeNewswire · February 12, 2026
EverCommerce Announces Date of Fourth Quarter 2025 Earnings Call
DENVER, Feb. 12, 2026 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, will report its fourth quarter 2025 financial results after the U.S. financial markets close on Thursday, March 12, 2026.
By EverCommerce Inc. · Via GlobeNewswire · February 12, 2026
Interfor Reports Q4’25 Results
Adjusted EBITDA loss of $29 million and Net Loss of $105 million
By Interfor Corporation · Via GlobeNewswire · February 12, 2026
Parker Scheduled to Present at Citi’s 2026 Global Industrial Tech and Mobility Conference on February 19 at 11:20 a.m. Eastern Time
CLEVELAND, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that it is scheduled to present at Citi’s 2026 Global Industrial Tech and Mobility Conference in Miami, Florida on February 19, 2026 at 11:20 a.m. Eastern time. A live webcast of the presentation will be accessible on Parker's investor information website at investors.parker.com and will be archived on the site.
By Parker-Hannifin Corporation · Via GlobeNewswire · February 12, 2026
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26
By mdxhealth · Via GlobeNewswire · February 12, 2026
Columbus Circle Capital Corp. II and Cohen & Company Inc. Announce Completion of $230,000,000 Initial Public Offering
  
By Columbus Circle Capital Corp II · Via GlobeNewswire · February 12, 2026
KYNDRYL HOLDINGS, INC. (KD) INVESTOR ALERT Investors With Large Losses in Kyndryl Holdings, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD) between August 7, 2024 and February 9, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · February 12, 2026
D. Boral Acquisition I Corp. Announces Closing of $287,500,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
New York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- D. Boral Acquisition I Corp. (the “Company”) today announced the closing of its initial public offering of 28,750,000 units, which includes 3,750,000 units issued pursuant to the full exercise by the underwriters of their over-allotment option, at a price of $10.00 per unit for total gross proceeds of $287,500,000. The units began trading on The Nasdaq Global Market under the ticker symbol “DBCAU” on February 11, 2026. Each unit consists of one of the Company’s Class A ordinary shares and one-half of one redeemable public warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be traded on The Nasdaq Global Market under the symbols “DBCA” and “DBCAW,” respectively.  The Company intends to use the net proceeds from the offering and the simultaneous private placement of units to pursue and consummate a business combination with one or more businesses.
By D. Boral Acquisition I Corp. · Via GlobeNewswire · February 12, 2026
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026
ROCKVILLE, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company expects to report fourth quarter and full year 2025 financial and business results after the market closes on Tuesday, February 24, 2026.
By Supernus Pharmaceuticals, Inc. · Via GlobeNewswire · February 12, 2026
CORRECTION: AIM ImmunoTech Announces Commencement of Rights Offering
This press release is issued solely to correct a date from an AIM press release dated February 11, 2026. The Subscription Rights will expire if they are not exercised by 5:00 p.m., Eastern Time, on February 27, 2026, the expected expiration date of the Rights Offering.
By AIM ImmunoTech Inc. · Via GlobeNewswire · February 12, 2026
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Beyond Meat, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BYND
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
MONAT Unleashed Ignites Munich: Over 800 Market Partners Gather at BMW Welt for a Powerful Celebration of Growth Across Europe
MUNICH, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Energy, innovation, and European momentum took center stage as more than 800 MONAT Market Partners from across Germany, Austria, and surrounding markets gathered at the ultra-modern BMW Welt & Museum for MONAT Unleashed Germany. The brand’s first major event since expanding into Germany eight months ago made a powerful statement of growth, innovation, and renewed connection.
By Monat Global · Via GlobeNewswire · February 12, 2026
Voodoo Doughnut to Open First Miami Location on February 19th
Legendary doughnut shop celebrates its Miami debut with free doughnuts, opening-day giveaways, and a partnership supporting NAMI Miami-Dade.
By Voodoo Doughnut · Via GlobeNewswire · February 12, 2026
Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
Collaboration with Mayo Clinic aims to accelerate regulatory approval and commercialization of Lumee™ wearable continuous tissue oxygen monitoring product
By Profusa, Inc. · Via GlobeNewswire · February 12, 2026
GB Capital Ltd. Co-Advises on the Acquisition of SVM Machining, Inc.
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- GB Capital Ltd. (“GB Capital”), a strategic finance, advisory and management firm, today announced that it served as co-advisor to PMGC Holdings  Inc. (NASDAQ: ELAB) (“PMGC”) in connection with PMGC’s acquisition of SVM Machining, Inc. (“SVM”), a Northern California–based ISO 9001:2015 certified CNC precision machining company.
By GB Capital Ltd. · Via GlobeNewswire · February 12, 2026
Advantage Solutions Strengthens Senior Leadership to Accelerate Growth Strategy
New appointments and expanded roles position company for sustained performance
Rocket Lab Prepares To Launch Latest Hypersonic Test Mission for Defense Innovation Unit
LONG BEACH, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced its next launch is a dedicated mission on its HASTE rocket for the Department of War’s Defense Innovation Unit (DIU).
By Rocket Lab Corporation · Via GlobeNewswire · February 12, 2026
Wix to Announce Fourth Quarter and Full Year 2025 Earnings Results on March 4, 2026
NEW YORK -- Wix.com Ltd. (Nasdaq: WIX), today announced that it will report its results for the fourth quarter and full year ended December 31, 2025 before the market opens on Wednesday, March 4, 2026. Management will host a conference call and webcast that morning at 8:30 a.m. ET to answer questions about the Company's financial results. Prior to the conference call and webcast, Wix will issue a press release reporting these results along with a shareholder update and additional materials at https://investors.wix.com/. 
By Wix.com, Ltd. · Via GlobeNewswire · February 12, 2026
Update on Trump Media Digital Token Initiative
Brokers Reminded of Tomorrow’s Deadline
By Trump Media & Technology Group · Via GlobeNewswire · February 12, 2026
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will announce its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026.
By Profound Medical Corp. · Via GlobeNewswire · February 12, 2026
Weatherford Awarded Multi-Year Integrated Completions Contract in Denmark
HOUSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc (NASDAQ: WFRD) (“Weatherford” or the “Company”) today announced it has been awarded a multi-year Integrated Completions contract by TotalEnergies in Denmark. The contract underscores TotalEnergies’ confidence in Weatherford’s technical expertise, execution capabilities, and commitment to delivering innovative, high-quality well solutions.
By Weatherford International, LLC · Via GlobeNewswire · February 12, 2026
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
AUDUBON, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ended December 31, 2025 after the market close on Tuesday, February 24, 2026. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
By Globus Medical · Via GlobeNewswire · February 12, 2026
Root, Inc. to Participate in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference
COLUMBUS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance, today announced its participation in the 2026 Association of Insurance and Financial Analysts (AIFA) Conference, taking place March 1-3, 2026, in Naples, Florida.
By Root, Inc. · Via GlobeNewswire · February 12, 2026
Cenovus to hold fourth-quarter and full-year 2025 conference call and webcast on February 19
CALGARY, Alberta, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) will release its fourth-quarter and full-year 2025 results on Thursday, February 19, 2026. The news release will provide consolidated fourth-quarter and full-year operating and financial information. The company’s financial statements will be available on Cenovus’s website, cenovus.com.
By Cenovus Energy Inc. · Via GlobeNewswire · February 12, 2026
Cal-Maine Foods Announces the Passing of Board Member Jim Poole, Honoring His Life and Service
RIDGELAND, Miss., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ: CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced with deep sadness the passing of Jim Poole, a valued member of its Board of Directors.
By Cal-Maine Foods, Inc. · Via GlobeNewswire · February 12, 2026
Mercer International Inc. Reports Fourth Quarter 2025 and Year End 2025 Results
Selected Highlights
By Mercer International Inc. · Via GlobeNewswire · February 12, 2026
J & J SNACK FOODS CORP. ANNOUNCES QUARTERLY CASH DIVIDEND
MOUNT LAUREL, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) -- J & J Snack Foods Corp. (Nasdaq: JJSF) announced today that its Board of Directors has declared a quarterly cash dividend of $0.80 per share of its common stock payable on April 7, 2026, to shareholders of record as of the close of business on March 17, 2026.
By J & J Snack Foods Corp. · Via GlobeNewswire · February 12, 2026
Constellation Brands Announces CEO Succession Plan
Nicholas Fink to Succeed Bill Newlands as President and Chief Executive Officer Effective April 13, 2026, Newlands to Serve as Strategic Advisor to Help Ensure a Smooth Leadership Transition
By Constellation Brands, Inc. · Via GlobeNewswire · February 12, 2026
Mohawk Industries Reports Q4 2025 Results
CALHOUN, Ga., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced fourth quarter 2025 net earnings of $42 million and earnings per share (“EPS”) of $0.68; adjusted net earnings were $124 million, and adjusted EPS was $2.00. Net sales for the fourth quarter of 2025 were $2.7 billion, up 2.4% as reported and down 3.3% on an adjusted basis versus the prior year. During the fourth quarter of 2024, the Company reported net sales of $2.6 billion, net earnings of $90 million and earnings per share of $1.43; adjusted net earnings were $123 million, and adjusted EPS was $1.95.
By Mohawk Industries, Inc. · Via GlobeNewswire · February 12, 2026
SiriusPoint announces IMG’s acquisition of global travel insurance and lifestyle brand World Nomads
HAMILTON, Bermuda, Feb. 12, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced that International Medical Group (“IMG”), a leader in global insurance benefits and assistance services, and SiriusPoint’s wholly owned subsidiary, will acquire World Nomads, a division of Australian health insurer, nib Group.
By SiriusPoint Ltd. · Via GlobeNewswire · February 12, 2026
NervGen Pharma Announces Retirement of Chief Financial Officer, Bill Adams
VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (“NervGen” or the “Company") (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions, today announced that Bill Adams will retire as Chief Financial Officer, effective March 15th, 2026. The Company has engaged a leading executive search firm to identify a successor, and Mr. Adams will continue in an advisory capacity following his retirement date to support the transition.
By NervGen Pharma Corp. · Via GlobeNewswire · February 12, 2026
H2O America to Report Fourth-Quarter and Full-Year 2025 Financial Results on February 25
SAN JOSE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- H2O America (NASDAQ: HTO) expects to report its financial results for the fourth quarter and full-year 2025 and provide forward-looking guidance after the close of the market on Wednesday, February 25, 2026.
By H2O America · Via GlobeNewswire · February 12, 2026
DraftKings Reports Fourth Quarter Revenue Growth of 43%
Reported Positive Net Income Set Records for Revenue and Adjusted EBITDA
By DK Crown Holdings Inc. · Via GlobeNewswire · February 12, 2026
Macerich Declares the Quarterly Dividend on Its Common Shares
SANTA MONICA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of The Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on March 30, 2026, to stockholders of record at the close of business on March 16, 2026.
By Macerich Company · Via GlobeNewswire · February 12, 2026
Taco John’s Brings Back SEA-sonal Seafood Favorites Featuring Wild-Caught Alaska Pollock
Fan-Favorite Fish Taco Returns Alongside New Premium Big Fish Sandwich
By Taco John's · Via GlobeNewswire · February 12, 2026
PureCycle Schedules Fourth Quarter and Fiscal Year Ending 2025 Corporate Update
ORLANDO, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- PureCycle Technologies, Inc. (Nasdaq: PCT), a U.S.-based company revolutionizing plastic recycling, will host a conference call on Thursday, February 26, 2026 to provide an update on recent corporate developments. A press release discussing such developments and other activity from the fourth quarter and fiscal year ending December 31, 2025, will be provided prior to the conference call.
By PureCycle Technologies · Via GlobeNewswire · February 12, 2026
SPS Commerce Appoints New Independent Directors to the Board
Enters into Cooperation Agreement with Anson Funds
By SPS Commerce, Inc. · Via GlobeNewswire · February 12, 2026
SOLV Energy Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN DIEGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced the closing of its initial public offering of 23,575,000 shares of its Class A common stock, which includes the exercise in full by the underwriters of their option to purchase 3,075,000 additional shares, at the initial public offering price of $25.00 per share, less underwriting discounts and commissions. All of the shares were offered by the Company.
By SOLV Energy, Inc. · Via GlobeNewswire · February 12, 2026
CCS Fundraising Releases Fifth Annual Philanthropy Pulse Report on the Forces Shaping Nonprofit Fundraising in 2026
New York, NY, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CCS Fundraising today announced the release of its fifth annual Philanthropy Pulse report, drawing on survey responses from more than 600 nonprofit organizations to examine how fundraising leaders are navigating a rapidly shifting philanthropic landscape and where they are focusing strategy for the year ahead.The 2026 CCS Philanthropy Pulse offers a snapshot of how nonprofit leaders are responding to increased complexity across revenue, staffing, policy, and technology, and how they are approaching the year ahead.Taken together, the findings suggest a sector that is adapting—not retreating—as leaders prioritize sustainability, structure, and thoughtful use of resources. “Nonprofit leaders are working in a dynamic moment of real change, and what stands out is their determination to adapt,” said Lindsay Marciniak, Managing Partner at CCS Fundraising. “This year’s Philanthropy Pulse highlights an industry that is actively refining strategy, utilizing new technology, and finding new ways to engage donors in meaningful, effective ways.”The report analyzes trends across organizational size and mission focus, offering insight into how nonprofits are responding to changing donor behavior, financial considerations, and operational needs.Key takeaways from the 2026 CCS Philanthropy Pulse reflect how nonprofit leaders are navigating growth and complexity across multiple dimensions:
By CCS Fundraising · Via GlobeNewswire · February 12, 2026
SPS Commerce Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Company delivers 100th consecutive quarter of topline growth
By SPS Commerce, Inc. · Via GlobeNewswire · February 12, 2026
Coherus Oncology, Inc. Announces Proposed Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced a proposed underwritten public offering of its common stock (the “Offering”). In addition, Coherus intends to grant the underwriters a 30-day option to purchase additional shares of its common stock in an amount up to 15% of the shares offered in the Offering, at the public offering price per share less underwriting discounts and commissions. All of the shares in the Offering are being offered by Coherus.
By Coherus Oncology, Inc. · Via GlobeNewswire · February 12, 2026
Phillips Edison & Company Declares Monthly Dividends
CINCINNATI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or “the Company”), one of the nation’s largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, today announced that the Company’s Board of Directors declared monthly dividend distributions of $0.1083 per share of the Company’s common stock payable on April 1, 2026; May 1, 2026; and June 2, 2026 to stockholders of record as of March 16, 2026; April 15, 2026; and May 15, 2026, respectively.
By Phillips Edison & Company, Inc. · Via GlobeNewswire · February 12, 2026
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results.
By OrthoPediatrics Corp. · Via GlobeNewswire · February 12, 2026
Flux Power Reports Fiscal Year 2026 Second Quarter Financial Results
VISTA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions and software-driven electrification for commercial and industrial equipment, today reported financial and operational results for the 2026 fiscal second quarter ended December 31, 2025.
By Flux Power · Via GlobeNewswire · February 12, 2026
Hubbell to Participate in Upcoming Investor Conference
Shelton, CT, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced that Gerben Bakker, Chairman and Chief Executive Officer, and Joe Capozzoli, Chief Financial Officer, will appear at the Barclays Industrial Select Conference. The event will be webcast and is scheduled to begin at 8:40AM ET on Thursday, February 19, 2026.
By Hubbell Inc. · Via GlobeNewswire · February 12, 2026
Roadzen Reports Strongest Quarter in Two Years with $14.4 Million Third Quarter Revenue and Sixth Consecutive Quarter of Adjusted EBITDA Improvement
Roadzen delivers 18.8% revenue increase and reduces operating loss by 25.4% over prior-year quarter
By Roadzen Inc. · Via GlobeNewswire · February 12, 2026
AvePoint to Participate in Upcoming Investor Conferences
JERSEY CITY, N.J., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX: AVP), the global leader in AI data protection, unifying data security, governance, and resilience, today announced that members of the Company’s executive management team will present at the following investor conferences: 
By AvePoint, Inc. · Via GlobeNewswire · February 12, 2026
Amwell® Announces Results for Fourth Quarter and Full Year 2025
BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the fourth quarter and full year ended December 31, 2025. The company’s fourth quarter and full year 2025 earnings report can be viewed at investors.amwell.com.
By Amwell · Via GlobeNewswire · February 12, 2026
Six Coherent Products Recognized by Lightwave Innovation Awards
SAXONBURG, Pa., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, proudly announced that six of its products have received awards in the 2026 Lightwave Innovation Reviews, matching the Company’s achievement in 2025 and underscoring Coherent’s continued leadership in optical networking innovation.
By Coherent Corp. · Via GlobeNewswire · February 12, 2026
Caribou Biosciences to Participate in Upcoming Investor Conferences
BERKELEY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced management will participate in the following investor conferences:
By Caribou Biosciences, Inc. · Via GlobeNewswire · February 12, 2026
Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today reported financial results and provided a business update for the three months ended December 31, 2025.
By Rezolute, Inc. · Via GlobeNewswire · February 12, 2026
BBOT to Participate in Upcoming Investor Healthcare Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today announced that members of its leadership team will participate in two investor conferences in the upcoming months.
By TheRas, Inc. (d/b/a BBOT) · Via GlobeNewswire · February 12, 2026
Scully Royalty Ltd. Board of Directors Announces that Tacora Resources Inc. has Commenced an Interpleader Action with respect to the January Royalty Payment
Stuart, Florida, Feb. 12, 2026 (GLOBE NEWSWIRE) -- MILFAM LLC (“MILFAM”), on behalf of the Board of Directors (the “Board”) of Scully Royalty Ltd. (NYSE:SRL) (“Scully”), announced that on February 11, 2026, Tacora Resources Inc. (“Tacora”) commenced an interpleader action in the Ontario Superior Court of Justice (“Court”), naming as respondents Scully, 1128349 B.C. Ltd. (“112”), MILFAM and the individual members of the Board to pay the January 2026 royalty payment into the Court. The application was commenced after the former Scully board of directors and management demanded payment from Tacora of a royalty owing under a mining lease to which 112 and Tacora are parties. The Board believes that the demand was made by individuals who lacked lawful authority to do so. The Board had previously sought to safeguard the payment.
By Milfam LLC · Via GlobeNewswire · February 12, 2026
Serotonin Centers Opens Naperville Location at Block 59, Marking Brand’s Entry into the Chicago Market
NAPERVILLE, Ill., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Serotonin Centers, a national leader in science-backed longevity, hormone optimization, and medical aesthetics, announced the opening of its newest location in Naperville, Illinois. Officially opening January 22, 2026, the Naperville center represents the brand’s first Illinois location and marks a major milestone in its continued national expansion.
By Serotonin · Via GlobeNewswire · February 12, 2026
ROSEN, THE FIRST FILING FIRM, Encourages agilon health, inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AGL
NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · February 12, 2026
Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
BEDFORD, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its fourth quarter and year-end 2025 financial results before the opening of the market on Thursday, February 26, 2026, followed by a conference call at 8:30 a.m. ET to discuss its results and business highlights.
By Anika Therapeutics Inc. · Via GlobeNewswire · February 12, 2026
Arhaus Appoints Michael Rengel as Chief Merchandising Officer
BOSTON HEIGHTS, Ohio, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a growing lifestyle brand and omni-channel retailer of premium artisan-crafted home furnishings, announced that Michael Rengel has been appointed Chief Merchandising Officer, effective February 23, 2026.
By Arhaus, Inc. · Via GlobeNewswire · February 12, 2026
Applied Materials Announces First Quarter 2026 Results
SANTA CLARA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Applied Materials, Inc. (NASDAQ : AMAT) today reported results for its first quarter ended Jan. 25, 2026.
By Applied Materials, Inc. · Via GlobeNewswire · February 12, 2026
Freehold Royalties Declares Dividend for February 2026
CALGARY, Alberta, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.09 per common share to be paid on March 16, 2026 to shareholders of record on February 27, 2026.
By Freehold Royalties Ltd. · Via GlobeNewswire · February 12, 2026
Pacira to Report 2025 Financial Results on Thursday February 26, 2026
BRISBANE, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will report its fourth quarter and year ended December 31, 2025 financial results after the close of the U.S. markets on Thursday February 26, 2026. Following the release, the company will host a live conference call and webcast at 4:30 p.m. ET.
By Pacira BioSciences · Via GlobeNewswire · February 12, 2026